Interferon

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Mri Data Showing Tysabri® Promoted Remyelination Presented At The 61st Annual Meeting Of The American Academy Of ...

Published July 4, 2009, 4:10 am, Medical News Today

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced results of a study demonstrating that TYSABRI® (natalizumab) promoted regeneration and stabilization of damage done to the myelin sheath, as measured by advanced MRI technology. Damage to the myelin sheath causes the symptoms of multiple sclerosis (MS).

Discover News | Full Story


First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis ...

Published July 4, 2009, 4:10 am, Medical News Today

Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subjects AVONEX MS Prevention Study).

Discover News | Full Story


Interferon Alpha Can Delay Full Onset Of Type I Diabetes: UT Researcher

Published July 3, 2009, 4:07 am, Medical News Today

A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston. The results of the Phase II trial are published in Diabetes Care, a journal of the American Diabetes Association.

Discover News | Full Story


Experts Warn of Idaho's Skin Cancer Rates

Published July 2, 2009, 11:41 am, KIVI Boise

The Idaho Department of Health and Welfare says the Gem State has some of the highest rates of melanoma diagnoses and deaths in the country.

Discover News | Full Story


Symptoms and treatment for multiple sclerosis

Published July 2, 2009, 10:34 am, Anderson Independent-Mail

Multiple sclerosis (MS) is a disease of the central nervous system that results in miscommunication between the brain and other parts of the body.

Discover News | Full Story


Assistant Managing Editor

Published July 1, 2009, 5:42 pm, BioWorld

It wasn't the acquisition some investors had hoped for, but Acorda Therapeutics Inc. hardly could have asked for better terms in its ex-U.S. licensing deal for multiple sclerosis drug Fampridine-SR.

Discover News | Full Story


Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, ...

Published July 1, 2009, 4:12 pm, Lancet

Idiopathic pulmonary fibrosis is a fatal disease for which no effective treatment exists. We assessed whether treatment with interferon gamma-1b improved survival compared with placebo in patients with idiopathic pulmonary fibrosis and mild-to-moderate impairment of pulmonary function.

Discover News | Full Story


Interferon Alpha May Delay Full Onset Of Type I Diabetes

Published July 1, 2009, 8:32 am, redOrbit

A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.The results of the Phase II trial are published today in Diabetes Care, a journal of the American Diabetes Association."It shows a strong trend in preserving ...

Discover News | Full Story


'Holey' Nanosheets for Wastewater Dye Removal

Published July 1, 2009, 7:18 am, PhysOrg

(PhysOrg.com) -- Researchers have discovered that extremely thin sheets of nickel oxide with hexagonally shaped holes can absorb hazardous dyes from wastewater nearly as well as the best traditional methods, but are recyclable. The research was reported recently in the journal Nanotechnology.

Discover News | Full Story


Interferon Alpha Can Delay Full Onset Of Type I Diabetes, Phase II Trial Suggests

Published July 1, 2009, 6:21 am, Science Daily

A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to the results of a Phase II trial.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a